52 Week Range
As of on the XETRA ∙ Minimum 15 minute delay
3M AVG Volume
52 Week High
52 Week Low
Shares Out (MIL)
Market Cap (MIL)
Dividend (Yield %)
Bayer: FDA Approves Rivaroxaban For Blood Clots Prevention
Sensyne Health Says Expanded Collaboration Agreement With Bayer
Bayer And Arvinas Unveil Targeted Protein Degradation Joint Venture
Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.
Independent Chairman of the Supervisory Board
Chairman of the Management Board, Chief Executive Officer
Independent Vice Chairman of the Supervisory Board, Employee Representative
Wolfgang U. Nickl
Chief Financial Officer, Member of the Management Board
Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director
Price To Earnings (TTM)
Price To Sales (TTM)
Price To Book (MRQ)
Price To Cash Flow (TTM)
Total Debt To Equity (MRQ)
LT Debt To Equity (MRQ)
Return on Investment (TTM)
Return on Equity (TTM)
Bayer expects the number of claims in the United States related to Roundup herbicide to have surged in the third quarter, as the German drugs and pesticides maker tries to reach a settlement after earlier court rulings against it.
The following are some of the factors that may move German stocks on Monday:
An Australian farmer has launched a legal action against Bayer AG's agricultural chemicals unit Monsanto after being diagnosed with a type of cancer he says was caused by its weedkiller, a lawyer for the man said on Friday.
An Australian farmer has launched a legal case against Bayer AG's agricultural chemicals unit Monsanto after being diagnosed with a type of leukaemia, the Australian Broadcasting Commission reported on Thursday.
(This October 6 story has been refilled to correct "until February" to "until further notice" in headline and "new court date" to "court status conference" in paragraphs 1 & 6)
European shares were little changed in choppy trade on Monday, after their steepest weekly loss in two months, as bids in defensive shares outweighed nervousness ahead of crucial U.S.-China trade talks and Brexit negotiations.
Summaries for the Bundesliga on Saturday (start times are CET) Bayern München (0) 1 Scorers: R. Lewandowski 73 Yellow card: Thiago Alcântara 48, Perišić 95 Subs used: Perišić 60 (Tolisso), Müller 60 (Coman) Hoffenheim (0) 2 Scorers: S. Adamyan 54, S. Adamyan 79 Subs used...
German drugmaker Bayer on Tuesday said it is to spend more than 25 billion euros ($27.22 billion) on research and development at its agriculture unit over the next 10 years.
A genetically modified soy seed technology from Germany's Bayer set to launch soon in Brazil has sparked concern from some farmers who worry that other crops could be impacted by dicamba, a herbicide the biotech product is designed to tolerate.
Brazilian farmers are wary of the imminent introduction of a new genetically modified soy seed technology because of the risks associated with dicamba, a herbicide the biotech product is designed to tolerate.
Summaries for the Bundesliga on Saturday (start times are CET) Borussia Dortmund (1) 4 Scorers: Paco Alcácer 28, M. Reus 50, Raphaël Guerreiro 83, M. Reus 90 Subs used: Hazard 61 (Brandt), Weigl 78 (Witsel), Bruun Larsen 79 (Paco Alcácer) Bayer Leverkusen (0) 0 Yellow card...
Bayer <BAYGn.DE> management board members Hartmut Klusik and Kemal Malik will leave at the end of the year without a replacement, as the German drugmaker reduces its board to five seats to cut costs.
Bayer said on Tuesday that management board members Hartmut Klusik and Kemal Malik would leave the company at the end of the year without a replacement, reducing the German drugmaker's board to five seats. (Reporting by Ludwig Burger Editing by Tassilo Hummel)
A Brazilian judge has ordered Germany's Bayer <BAYGn.DE> to deposit an additional 286 million reais (56.6 million pounds) in an escrow account due to a patent dispute with local soybean farmers, according to a court decision seen by Reuters.
A Brazilian judge has ordered Germany's Bayer to deposit an additional 286 million reais ($69.4 million) in an escrow account due to a patent dispute with local soybean farmers, according to a court decision seen by Reuters.
Bayer <BAYGn.DE> said it hired Johnson & Johnson <JNJ.N> executive Marianne De Backer to manage acquisitions and licensing deals at its drugs unit, as the German drugmaker turns to outside sources to boost its development pipeline.
Top Scorers in the Bundesliga on Friday 1 Paco Alcácer (Borussia Dortmund) 3 2 R. Lewandowski (Bayern München) 2 J. Sancho (Borussia Dortmund) 3 M. Arnold (Wolfsburg) 1 K. Ayhan (Düsseldorfer TuS Fortuna 1895) L. Bailey (Bayer Leverkusen) J. Brandt (Borussia Dortmund) D...
Summaries for the Bundesliga on Friday (start times are CET) Köln (1) 1 Scorers: D. Drexler 29 Yellow card: Verstraete 46, Ehizibue 90 Subs used: Terodde 55 (Córdoba), Kainz 74 (Schindler), Höger 81 (Modeste) Borussia Dortmund (0) 3 Scorers: J. Sancho 70, A. Hakimi 86, Paco...
Bayer AG <BAYGn.DE> is in mediation to potentially settle thousands of U.S. lawsuits claiming that the company's Roundup weed killer causes cancer, but some legal experts said the cases raises novel questions that may prevent an easy settlement.
Elanco Animal Health <ELAN.N> agreed to buy Bayer's <BAYGn.DE> veterinary drugs unit on Tuesday in a cash and stock deal valued at $7.6 billion (£6.3 billion), creating the second largest maker of medicines for pets and livestock and expanding Elanco's reach online.
Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.